RECURSION PHARMACEUTICALS, INC. reports

Company location: Salt Lake City, UT
Fiscal year end: 31 December

RECURSION PHARMACEUTICALS, INC. has filed 953 SEC EDGAR filings since 02 Apr 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 676-700 of 953 matching filings.

Per page

25

Current page

28

4

FORM 4 SUBMISSION

Filing date: 05 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-40323

144 filing

Filing date: 05 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-40323

144 filing

Filing date: 04 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Mar 2023
Reporting date: 21 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Mar 2023
Reporting date: 13 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Mar 2023
Reporting date: 08 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40323

8-K

Filing date: 10 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Mar 2023
Reporting date: 07 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 03 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 02 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 01 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 28 Feb 2023
Reporting date: 27 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Feb 2023
Reporting date: 23 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-40323

10-K

Filing date: 27 Feb 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40323

8-K

Filing date: 27 Feb 2023
Reporting date: 27 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 27 Feb 2023
Reporting date: 24 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 24 Feb 2023
Reporting date: 23 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2023
Reporting date: 21 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 23 Feb 2023
Reporting date: 22 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 22 Feb 2023
Reporting date: 21 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 21 Feb 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

RXRX - CHANGES IN BENEFICIAL OWNERSHIP

Filing date: 17 Feb 2023
Reporting date: 16 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Feb 2023
Reporting date: 15 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .